drugset / Trial / NCT01105130

L-Arginine Supplementation With or Without Enzyme Inhibitors Treating Erectile Function of Prostate Cancer Survivors

NCT01105130

RandomizedParallel-groupQuadruple-blindSupportive care

Summary

RATIONALE: L-arginine supplements may improve the quality of life and erectile function in men who are prostate cancer survivors. PURPOSE: This randomized phase II trial is studying how well L-arginine supplementation works with or without enzyme inhibitors in treating erectile function and quality of life of prostate cancer survivors previously treated with radiation therapy.

Timeline

Start
2010-10-01
Primary completion
2014-02-04
Completion
2014-02-04

Drugs

EvaluationDrugModalityDoseRoute
Subject L-arginine Small molecule Oral